User menu

A MAGE-A4 peptide presented by HLA-B37 is recognized on human tumors by cytolytic T lymphocytes.

Bibliographic reference Zhang, Y. ; Stroobant, Vincent ; Russo, V ; Boon, Thierry ; van der Bruggen, Pierre. A MAGE-A4 peptide presented by HLA-B37 is recognized on human tumors by cytolytic T lymphocytes.. In: Tissue antigens, Vol. 60, no. 5, p. 365-71 (2002)
Permanent URL
  1. De Plaen E, Immunogenetics, 40, 360 (1994)
  2. Lurquin Christophe, De Smet Charles, Brasseur Francis, Muscatelli Françoise, Martelange Valérie, De Plaen Etienne, Brasseur Robert, Monaco Anthony P., Boon Thierry, Two Members of the HumanMAGEBGene Family Located in Xp21.3 Are Expressed in Tumors of Various Histological Origins, 10.1006/geno.1997.5052
  3. Lucas S, Cancer Res, 58, 743 (1998)
  4. Chomez P, Cancer Res, 61, 5544 (2001)
  5. HAAS GILBERT G., D'CRUZ OSMOND J., DE BAULT LAWRENCE E., Distribution of Human Leukocyte Antigen-ABC and -D/DR Antigens in the Unfixed Human Testis, 10.1111/j.1600-0897.1988.tb00234.x
  6. Hunt DF, Science, 255, 1261 (1992)
  7. Marchand M, Exp Opin Biol Ther, 1, 497 (2001)
  8. Jäger Elke, Jäger Dirk, Knuth Alexander, Clinical cancer vaccine trials, 10.1016/s0952-7915(02)00318-7
  9. Marchand Marie, van Baren Nicolas, Weynants Patrick, Brichard Vincent, Dr�no Brigitte, Tessier Marie-H�l�ne, Rankin Elaine, Parmiani Giorgio, Arienti Flavio, Humblet Yves, Bourlond Andr�, Vanwijck Romain, Li�nard Danielle, Beauduin Marc, Dietrich Pierre-Yves, Russo Vincenzo, Kerger Joseph, Masucci Giuseppe, J�ger Elke, De Greve Jacques, Atzpodien Jens, Brasseur Francis, Coulie Pierre G., van der Bruggen Pierre, Boon Thierry, Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by geneMAGE-3 and presented by HLA-A1, 10.1002/(sici)1097-0215(19990118)80:2<219::aid-ijc10>;2-s
  10. Thurner Beatrice, Haendle Ina, Röder Claudia, Dieckmann Detlef, Keikavoussi Petra, Jonuleit Helmut, Bender Armin, Maczek Christian, Schreiner Doris, von den Driesch Peter, Bröcker Eva B., Steinman Ralph M., Enk Alexander, Kämpgen Eckhart, Schuler Gerold, Vaccination with Mage-3a1 Peptide–Pulsed Mature, Monocyte-Derived Dendritic Cells Expands Specific Cytotoxic T Cells and Induces Regression of Some Metastases in Advanced Stage IV Melanoma, 10.1084/jem.190.11.1669
  11. De Plaen Etienne, Naerhuyzen Bénédicte, De Smet Charles, Szikora Jean-Pierre, Boon Thierry, Alternative Promoters of Gene MAGE4a, 10.1006/geno.1996.4566
  12. Traversari C, Immunogenetics, 35, 145 (1992)
  13. Van Snick J, J Exp Med, 165, 641 (1987)
  14. Mavilio F, Blood, 83, 1988 (1994)
  15. Espevik Terje, Nissen-Meyer Jon, A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes, 10.1016/0022-1759(86)90322-4
  16. Hansen Morten Bagge, Nielsen Svend Erik, Berg Kurt, Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill, 10.1016/0022-1759(89)90397-9
  17. Chaux P, MAGE-A1 J Immunol, 163, 2928 (1999)
  18. Rammensee Hans-Georg, Bachmann Jutta, Stevanović Stefan, MHC Ligands and Peptide Motifs, ISBN:9783662221648, 10.1007/978-3-662-22162-4
  19. Falk K, Immunogenetics, 38, 161 (1993)
  20. Schultz E.S., Zhang Y., Knowles R., Tine J., Traversari C., Boon T., van der Bruggen P., A MAGE-3 peptide recognized on HLA-B35 and HLA-A1 by cytolytic T lymphocytes, 10.1034/j.1399-0039.2001.057002103.x
  21. Luiten R., van der Bruggen P., A MAGE-A1 peptide is recognized on HLA-B7 human tumors by cytolytic T lymphocytes, 10.1034/j.1399-0039.2000.550206.x
  22. Traversari C, J Exp Med, 176, 1453 (1992)
  23. van der Bruggen P, Eur J Immunol, 24, 2134 (1994)
  24. 25. P van der Bruggen, Y Zhang, and P Chaux et al.Tumor-specific shared antigenic peptides recognized by human T cells . Immunol Rev, in. press.
  25. Chen CH, Liver, 19, 110 (1999)
  26. Dalerba Piero, Frascella Emanuela, Macino Beatrice, Mandruzzato Susanna, Zambon Annalisa, Rosolen Angelo, Carli Modesto, Ninfo Vito, Zanovello Paola, MAGE, BAGE andGAGE gene expression in human rhabdomyosarcomas, 10.1002/ijc.1307